University of the Mediterranean & Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, Marseille, France.
Eur J Cardiothorac Surg. 2011 Aug;40(2):309-19. doi: 10.1016/j.ejcts.2010.11.036. Epub 2011 Jan 8.
Lung cancer remains the main leading cancer-related cause of death in the world. For early-stage tumor, surgery stands out as the best curative option offering the greatest chance for cure. Despite improvement of per- and postoperative management, surgery continues to carry a high morbidity with a significant mortality. Among postoperative complications, respiratory failures (nosocomial pneumonia and acute respiratory distress syndrome) are currently the most frequent and serious, as well as being the primary cause of hospital death, after a lung resection for cancer. Because infectious etiologies have been highly incriminated in the development of these pulmonary complications, microbial airways colonizations (AWCs) are supposed to be an essential first step in the pathogenesis of these failures occurring in hospitalized and chronically ill individuals. These patients fulfill all the predisposing factors to bronchial colonizations and are particularly exposed to the development of respiratory failures in the postoperative setting, when secretion clearance and cough reflex are impaired. Under immunosuppressive conditions, AWC should act in a manner that increases its ability to stimulate microorganisms and increase the risks of superimposed infections. Few studies have addressed the problem of AWCs in patients submitted for lung cancer surgery. Because of several limitations, especially the lack of exhaustive microbiological studies, the conclusions that can be reached remain inconclusive. This review aims to report the existing literature on this critical and controversial issue, focusing on their specific incidence, their predisposing factors, their correlation with development of respiratory failures, and, in turn, the reliability of the current antibiotic prophylaxis for their prevention.
肺癌仍然是全球主要的癌症相关死亡原因。对于早期肿瘤,手术是最佳的治疗选择,提供了最大的治愈机会。尽管围手术期管理有所改善,但手术仍然存在高发病率和高死亡率。在术后并发症中,呼吸衰竭(医院获得性肺炎和急性呼吸窘迫综合征)是目前最常见和最严重的并发症,也是癌症肺切除术后医院死亡的主要原因。由于感染病因在这些肺部并发症的发展中被高度怀疑,因此微生物气道定植(AWC)被认为是这些在住院和慢性病患者中发生的失败的发病机制的重要第一步。这些患者具备支气管定植的所有诱发因素,并且在术后清除分泌物和咳嗽反射受损时,特别容易发生呼吸衰竭。在免疫抑制的情况下,AWC 应该以一种增加其刺激微生物的能力并增加并发感染风险的方式发挥作用。很少有研究关注接受肺癌手术的患者的 AWC 问题。由于存在多种局限性,特别是缺乏详尽的微生物学研究,因此得出的结论仍不确定。这篇综述旨在报告关于这一关键和有争议问题的现有文献,重点关注其特定的发生率、其诱发因素、与呼吸衰竭发展的相关性,以及抗生素预防措施的可靠性。